About Indigo BioAutomation
Indigo BioAutomation is a company based in Indianapolis (United States) founded in 2004. It operates as a SaaS (Software-as-a-Service). Indigo BioAutomation has raised $12.35 million across 4 funding rounds from investors including Bootstrap Venture Partners. The company has 27 employees as of December 31, 2022. Indigo BioAutomation offers products and services including ASCENT and ARQ. Indigo BioAutomation operates in a competitive market with competitors including Waters Corporation, Tecan, Emerald Therapeutics, Quartzy and ChromaTan, among others.
- Headquarter Indianapolis, United States
- Employees 27 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Indigo Bioautomation
-
Annual Revenue
$174.96 K (USD)44as on Nov 30, 2023
-
Net Profit
$77.65 K (USD)40as on Nov 30, 2023
-
EBITDA
Not available
-
Total Equity Funding
$12.35 M (USD)
in 4 rounds
-
Latest Funding Round
$8.5 M (USD), Series B
May 16, 2014
- Investors
-
Employee Count
27
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Indigo BioAutomation
Indigo BioAutomation offers a comprehensive portfolio of products and services, including ASCENT and ARQ.
Software for LC-MS analysis is provided for labs.
PCR data analysis software is offered for laboratories.
People of Indigo BioAutomation
Unlock access to complete
Funding Insights of Indigo BioAutomation
Indigo BioAutomation has successfully raised a total of $12.35M across 4 strategic funding rounds. The most recent funding activity was a Series B round of $8.5 million completed in May 2014. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Indigo BioAutomation
Indigo BioAutomation has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Bootstrap Venture Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage investments are made in US companies across sectors.
|
Locked | Locked | Locked |
Investor details for Indigo BioAutomation
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Indigo BioAutomation
Investment portfolio details for Indigo BioAutomation
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Indigo BioAutomation
Detailed financials for Indigo BioAutomation
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Indigo Bioautomation Comparisons
Peer comparison for Indigo BioAutomation
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Indigo BioAutomation
Indigo BioAutomation operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Waters Corporation, Tecan, Emerald Therapeutics, Quartzy and ChromaTan, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of laboratory management system for researchers and clinicians
|
|
| Locked | Locked | Locked |
Automated laboratory instruments, robotics, and diagnostic solutions are provided.
|
|
| Locked | Locked | Locked |
Cloud-based remote lab automation software is offered for life sciences.
|
|
| Locked | Locked | Locked |
Lab management platform for life sciences is offered by Quartzy.
|
|
| Locked | Locked | Locked |
Continuous countercurrent tangential chromatography separation technology is developed.
|
|
| Locked | Locked | Locked |
SaaS-based laboratory information system is provided for clinicians.
|
Detailed competitors of Indigo BioAutomation
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Indigo Bioautomation
Complete news archive for Indigo BioAutomation
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Indigo BioAutomation
Indigo BioAutomation was founded in 2004 and raised its 1st funding round 2 years after it was founded.
Indigo BioAutomation is headquartered in Indianapolis, United States. It is registered at Indianapolis, Indiana, United States.
Indigo BioAutomation is a funded company, having raised a total of $12.35M across 4 funding rounds to date.
As of Dec 31, 2022, the latest employee count at Indigo BioAutomation is 27.
Annual revenue of Indigo BioAutomation is $174.96K as on Nov 30, 2023.
Advanced laboratory automation solutions are provided by Indigo BioAutomation. Focus is placed on chromatography, mass spectrometry, and PCR data analysis. Products like ASCENT and ARQ are designed to enhance workflow efficiency, throughput, and data insights. Continuous validation monitoring is enabled alongside lab-wide data review. Hosted SaaS systems are offered for flexible data access. AI and ML technologies are utilized for operational transformation in clinical and life science laboratories.
Indigo BioAutomation's top competitors include Tecan, Waters Corporation and Automata.
Indigo BioAutomation offers ASCENT and ARQ.
Indigo BioAutomation has 1 investor. Key investors include Bootstrap Venture Partners.